trial · primary record
Apalutamide
Prostatic Neoplasms
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 2517 |
| Primary completion | 2028-10-13 |
| Primary endpoint | Percentage of Participants with Pathologic complete response (pCR) |
| Registry ID | NCT03767244 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:53.901Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03767244
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Apalutamide · compound